
Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate development.
Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate development.
While the summer months have been typically slow, we have made good progress on all fronts. We are currently finalizing the closing conditions required to formalize the exclusive licensing of an FDA approved drug from a U.S. Company focused on the development and production of generic radiopharmaceuticals. The expected addition of this asset to our pipeline will be extremely timely, as all stakeholders in the healthcare space look to make more affordable drugs available to patients.
Regarding our current asset, MAN-01 for the treatment of glaucoma, our partner, Mannin Research is progressing well in its pre-clinical lead candidate optimization of a small molecule for a topical route of administration.
Mannin is continuing strategic partnership discussions with companies and technologies that will strengthen Mannin’s intellectual property portfolio in the Tie2/TEK mechanism of action market. Mannin is also establishing research and development partnerships with non-governmental organizations to provide direct support for the MAN-01 program.
Q BioMed has been conducting due diligence on several other potential assets to expand the ophthalmology pipeline within Q BioMed. These include implantable devices and biomarker diagnostics. In addition, we have been working with additional potential advisory experts to add to our team. We will make details of these available as they materialize.
Our CEO Denis Corin was recently interviewed on The Stock Radio. The interview can be accessed here.
http://thestockradio.com/denis-corin-ceo-of-q-biomed-inc-qbio-3099.html
Connect with Q BioMed Inc. (OTCQB:QBIO) to receive an Investor Presentation.
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1853.48 | +0.45 | |
Silver | 22.12 | +0.03 | |
Copper | 4.32 | +0.06 | |
Palladium | 2076.57 | +13.05 | |
Platinum | 957.08 | +2.92 | |
Oil | 115.07 | +0.98 | |
Heating Oil | 3.90 | +0.05 | |
Natural Gas | 8.71 | -0.19 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.